Debate about placebos points to issue surrounded by many shades of grey.
Dr. Kenneth Rothman, a critic of the use of placebos in clinical trials, recently discussed the issue with Health Canada employees. Some researchers insist this is not a black-and-white issue, and that in some cases patients who receive a placebo are the lucky ones.
Baer
N
N
D001294:Attitude to Health; D002170:Canada; D035061:Control Groups; D018849:Controlled Clinical Trials as Topic / Q000379:methods*; D003863:Depression / Q000628:therapy; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use; D004992:Ethics, Medical; D033161:Government Regulation; D006801:Humans; D001523:Mental Disorders / Q000628:therapy; D028642:Persons with Psychiatric Disorders; D018579:Patient Selection; D010919:Placebos; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation
D015507:Drugs, Investigational; D010919:Placebos